Press Room

Releasing Insulin Like Clockwork

Scientists have shown that disruption of the body’s internal clock system is involved in a range of diseases, from psychiatric to metabolic to cardiovascular. 


Collaboration Leads to Invaluable Discoveries

In its early phase, encapsulation research was divided, with experts in different disciplines focused on different aspects of the science. JDRF created the Encapsulation Consortium in 2013, jump-starting the field by encouraging collaboration among its 25+ members and shaping a strategy to guide research....


JDRF in the Globe and Mail, November 12, 2015

JDRF showcases the remarkable people who benefit from JDRF-funded research while striving to accelerate the pace of research in Canada.


New Classification and Staging Approach for Presymptomatic Type 1

JDRF and the American Diabetes Association, in Collaboration with Multiple Diabetes Organizations Publish New Classification and Staging Approach for Presymptomatic Type 1. Diabetes Organizations Endorse Concept that Autoimmune Disease Begins Long Before Symptoms Occur and Progresses through Distinct ...


Corporate Canada Mounts Up at the Annual JDRF Ride for Diabetes Research

The stationary bicycles are tuned, greased and ready for corporate Canada to start cycling in support of JDRF at the 2015 JDRF Ride for Diabetes Research (JDRF Ride). This fall, all across Canada various business sectors will trade in their suits for sweats as they go head-to-head in this unique stationary ...


The U.S. National Institutes of Health support diabetes research at the IRCM

A Canadian research team working on the development of an external artificial pancreas is receiving a grant of $2,509,367 USD from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) of the U.S. National Institutes of Health (NIH).


ViaCyte Announces Highly Anticipated Encapsulation Clinical Trial Site Expansion into Canada

ViaCyte, Inc. announced the opening of a second site in its Phase 1/2 trial called STEP ONE, or Safety, Tolerability and Efficacy of VC-01™ Combination Product in Type One Diabetes (T1D), at the University of Alberta Hospital in Edmonton, Alberta funded in part by the JDRF Canadian Clinical Trial ...


MUHC conducts first islet cell transplant in Quebec

Innovative treatment for type 1 diabetes marks first step towards vision of regional network for islet cell isolation and transplant 


Two-year $300 Million Extension of the Special Diabetes Program Allows for the Continuation of Promising Ongoing Clinical Trials

The U.S. Senate overwhelmingly approved legislation last night for a two-year extension of the Special Diabetes Program (SDP)—an initiative that accounts for roughly one-third of all Federally-funded type 1 diabetes (T1D) research in the United States. The decision comes on the heels of the strong ...


JDRF-Supported Researchers Make Gains in Designing Islet Cell Encapsulation Materials for Use in Type 1 Diabetes Therapies

New study shows size and shape of encapsulation materials have an effect on islet cell survival


Lets turn type one into type none